Criterion Capital Advisors, LLC Eli Lilly & CO Transaction History
Criterion Capital Advisors, LLC
- $159 Billion
- Q2 2024
A detailed history of Criterion Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Criterion Capital Advisors, LLC holds 2,201 shares of LLY stock, worth $2 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
2,201
Previous 2,229
1.26%
Holding current value
$2 Million
Previous $1.73 Billion
14.92%
% of portfolio
1.25%
Previous 1.16%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
3,869Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$88.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$67 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$59.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$46.6 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$30.7 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $862B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...